Clinical Results on the Use of Human Ceruloplasmin in Aplastic Anemia

Transfusion - Tập 19 Số 6 - Trang 742-748 - 1979
M. Shimizu1
1Department of Medicine, Showa University School of Medicine, Tokyo, Japan

Tóm tắt

Frequent blood transfusions are necessary in aplastic anemia because of decreased hematopoietic function. In order to maintain the hemoglobin level and to decrease the need for blood transfusion, human ceruloplasmin was used for the treatment of 73 patients with aplastic anemia. A marked beneficial effect was obtained in 16 cases. The treatment was moderately effective in 17 cases, slightly effective in eight cases, and ineffective in 32 cases. The usual dose of ceruloplasmin was 15 mg/day, but it was varied according to symptoms. Side effects were minimal when ceruloplasmin was administered by slow intravenous injection.

Từ khóa


Tài liệu tham khảo

Aizawa T., 1974, Biosynthesis of nucleic acid in folic acid deficiency and hypoplastic anemia, Showa Med. J., 34, 403

Arimori S., 1966, Treatment on aplastic anemia, with special reference to ceruloplasmin, Jap. J. Clin. Exper. Med., 43, 1897

10.3181/00379727-94-22910

Gendel B. R., 1947, Folic acid in the treatment of aplastic anemia, J. Lab. Clin. Med., 32, 139

Katsunuma H., 1961, Clinical experience with ceruloplasmin on aplastic anemia, Jap. J. Clin. Med., 19, 424

Komiya E., 1956, Treatment of aplastic anemia, Jap. J. Clin. Med., 14, 860

10.1016/S0021-9258(18)96527-0

Rimington C., 1961, Role of mitochondria in the in vitro formation of protoporphyrine and haem, J. Biochem., 49, 456, 10.1093/oxfordjournals.jbchem.a127328

10.1172/JCI106460

Shimizu M.:Clinical and experimental studies of ceruloplasmin as erythropoietic factor. Proc. VIII Intern. Congress of Hematology.1960 p.979.

Shimizu M., 1970, Folic acid and ceruloplasmin, Acta Haematol. Jap., 33, 179

Shimizu M., 1968, Ceruloplasmin as a controlling factor of the hematopoietic system, Birth Defects Original Article Series (The National Foundation, N.Y.)., 5, 49

Shimizu M., 1973, Effect and mode of action of folic acid on hypolastic anemia, Acta Haematol. Jap., 36, 532

Yamamoto M., 1969, Erythropoietic mechanism by combined use of ceruloplasmin and folic acid, Acta Haematol. Jap., 32, 366

Yuri T., 1971, A case report of pure red cell aplasia treated with ceruloplasmin, Jpn. J. Med., 9, 1256

Thông tin
Thông tin xuất bản

Transfusion

Tập 19 Số 6

742-748

Thông tin tác giả